These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1379521)

  • 1. Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo.
    Satake-Ishikawa R; Ishikawa M; Okada Y; Kakitani M; Kawagishi M; Matsuki S; Asano K
    Cell Struct Funct; 1992 Jun; 17(3):157-60. PubMed ID: 1379521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
    Eliason JF; Greway A; Tare N; Inoue T; Bowen S; Dar M; Yamasaki M; Okabe M; Horii I
    Stem Cells; 2000; 18(1):40-5. PubMed ID: 10661570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein.
    Bowen S; Tare N; Inoue T; Yamasaki M; Okabe M; Horii I; Eliason JF
    Exp Hematol; 1999 Mar; 27(3):425-32. PubMed ID: 10089904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and its derivative ND 28 with polyethylene glycol.
    Yamasaki M; Asano M; Okabe M; Morimoto M; Yokoo Y
    J Biochem; 1994 May; 115(5):814-9. PubMed ID: 7525544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
    Ishikawa M; Okada Y; Satake-Ishikawa R; Kakitani M; Kawagishi M; Matsuki S; Kusaka M; Asano K
    Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
    Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity.
    Malik F; Delgado C; Knüsli C; Irvine AE; Fisher D; Francis GE
    Exp Hematol; 1992 Sep; 20(8):1028-35. PubMed ID: 1505637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of site-specific polyethylene glycol modification of recombinant human granulocyte colony-stimulating factor on its biologic activities.
    Hao Y; Chen J; Wang X; Zhu H; Rong Z
    BioDrugs; 2006; 20(6):357-62. PubMed ID: 17176123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF.
    Salmaso S; Bersani S; Mastrotto F; Tonon G; Schrepfer R; Genovese S; Caliceti P
    J Control Release; 2012 Aug; 162(1):176-84. PubMed ID: 22727711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of PEG-rhG-CSF and rHSA-hG-CSF in mice determined with ELISA].
    Ma GC; Chen SQ; Zhu ZH; Huang YS; Pan HQ; Zhou JB
    Yao Xue Xue Bao; 2007 Feb; 42(2):197-200. PubMed ID: 17518051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of microchip CGE for the analysis of PEG-modified recombinant human granulocyte-colony stimulating factors.
    Park EJ; Lee KS; Lee KC; Na DH
    Electrophoresis; 2010 Nov; 31(22):3771-4. PubMed ID: 20945411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a Long-Acting Site-Specific PEGylated Murine GM-CSF Analog and Analysis of Its Hematopoietic Properties in Normal and Cyclophosphamide-Treated Neutropenic Rats.
    Cox GN; Lee JI; Rosendahl MS; Chlipala EA; Doherty DH
    Protein J; 2020 Apr; 39(2):160-173. PubMed ID: 32172395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
    Nissen C
    Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral bioavailability of human granulocyte colony stimulating factor conjugated with poly(ethylene glycol).
    Jensen-Pippo KE; Whitcomb KL; DePrince RB; Ralph L; Habberfield AD
    Pharm Res; 1996 Jan; 13(1):102-7. PubMed ID: 8668656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activity.
    Knüsli C; Delgado C; Malik F; Dómine M; Tejedor MC; Irvine AE; Fisher D; Francis GE
    Br J Haematol; 1992 Dec; 82(4):654-63. PubMed ID: 1482652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant bovine granulocyte colony-stimulating factor covalently bound to polyethylene glycol injection on neutrophil number and function in periparturient dairy cows.
    Kimura K; Goff JP; Canning P; Wang C; Roth JA
    J Dairy Sci; 2014; 97(8):4842-51. PubMed ID: 24881799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged circulation and in vivo efficacy of recombinant human granulocyte colony-stimulating factor encapsulated in polymeric micelles.
    Harada M; Ohuchi M; Hayashi T; Kato Y
    J Control Release; 2011 Nov; 156(1):101-8. PubMed ID: 21723892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol.
    Paige AG; Whitcomb KL; Liu J; Kinstler O
    Pharm Res; 1995 Dec; 12(12):1883-8. PubMed ID: 8786961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.